An update on the use of C-reactive protein in early-Onset neonatal sepsis: Current insights and new tasks

Neonatology

Volumn 102, Issue 1, 2012, Pages 25-36

  Hofer, Nora ^a   Zacharias, Eva ^a   Müller, Wilhelm ^a   Resch, Bernhard ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

C reactive protein; Chemokines; Cytokines; Early neonatal period; Early onset neonatal sepsis; Gestational age; Infectious diseases; Neonatal intensive care; Newborn infant

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CYTOKINE; PROCALCITONIN;

ACUTE PHASE RESPONSE; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; BIRTH WEIGHT; CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG MONITORING; GESTATIONAL AGE; GOLD STANDARD; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; LABORATORY TEST; NEWBORN SEPSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; TREATMENT RESPONSE;

BACTERIA (MICROORGANISMS);

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HUMANS; INFANT, NEWBORN; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 85027936910     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000336629     Document Type: Review

References (28)

1. Weston EJ, Pondo T, Lewis MM, Martell- Cleary P, Morin C, Jewell B, et al: The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011; 30: 937-941.
2. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, et al: Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007; 196: 147.e1-8.
3. Murray BE: Can antibiotic resistance be controlled? N Engl J Med 1994; 330: 1229-1230.
4. Chiesa C, Panero A, Osborn JF, Simonetti AF, Pacifico L: Diagnosis of neonatal sepsis: a clinical and laboratory challenge. Clin Chem 2004; 50: 279-287.
5. Mishra UK, Jacobs SE, Doyle LW, Garland SM: Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 2006; 91:F208-F212.
6. Ng PC, Li K, Leung TF, Wong RPO, Li G, Chui KM, et al: Early prediction of sepsisinduced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants. Clin Chem 2006; 52: 1181-1189.
7. Chirico G, Loda C: Laboratory aid to the diagnosis and therapy of infection in the neonate. Pediatr Rep 2011; 3:e1.
8. Tillett WS, Francis T: Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930; 52: 561-571.
9. Pepys MB: C-reactive protein fifty years on. Lancet 1981; 1: 653-657.
10. Jaye DL, Waites KB: Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997; 16: 735-746.
11. Volanakis JE: Human C-reactive protein: expression, structure, and function. Mol Immunol 2001; 38: 189-197.
12. Du Clos TW: Function of C-reactive protein. Ann Med 2000; 32: 274-278.
13. Weinhold B, R̈ther U: Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochem J 1997; 327: 425-429.
14. Shine B, de Beer FC, Pepys MB: Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta 1981 25; 117: 13-23.
15. Rifai N, Ridker PM: Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. Clin Chem 2003; 49: 666-669.
16. Imhof A, Fröhlich M, Loewel H, Helbecque N, Woodward M, Amouyel P, et al: Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. Clin Chem 2003; 49: 669-672.
17. Vigushin DM, Pepys MB, Hawkins PN: Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91: 1351-1357.
18. Kääpä P, Koistinen E: Maternal and neonatal C-reactive protein after interventions during delivery. Acta Obstet Gynecol Scand 1993; 72: 543-546.
19. Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-1812.
20. Hengst JM: The role of C-reactive protein in the evaluation and management of infants with suspected sepsis. Adv Neonatal Care 2003; 3: 3-13.
21. Fowlie PW, Schmidt B: Diagnostic tests for bacterial infection from birth to 90 days - a systematic review. Arch Dis Child Fetal Neonatal Ed 1998; 78:F92-F98.
22. Benitz WE, Han MY, Madan A, Ramachandra P: Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998; 102:E41.
23. Pourcyrous M, Bada HS, Korones SB, Baselski V, Wong SP: Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993; 92: 431-435.
24. Kawamura M, Nishida H: The usefulness of serial C-reactive protein measurement in managing neonatal infection. Acta Paediatr 1995; 84: 10-13.
25. Laborada G, Rego M, Jain A, Guliano M, Stavola J, Ballabh P, et al: Diagnostic value of cytokines and C-reactive protein in the first 24 h of neonatal sepsis. Am J Perinatol 2003; 20: 491-501.
26. Wagle S, Grauaug A, Kohan R, Evans SF: Creactive protein as a diagnostic tool of sepsis in very immature babies. J Paediatr Child Health 1994; 30: 40-44.
27. Mathers NJ, Pohlandt F: Diagnostic audit of C-reactive protein in neonatal infection. Eur J Pediatr 1987; 146: 147-151.
28. Resch B, Gusenleitner W, M̈ller WD: Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr 2003; 92: 243-245.